Sanofi got more than it bargained for when it teamed up with the U.S. Army to develop a Zika shot.
The CDC is recommending PaxVax’s Vaxchora, the only FDA-approved cholera vaccine, for adults aged 18 to 64 traveling to areas where cholera is active.
The U.S. could run into a vaccine supply predicament if an influenza pandemic hits, since only one drugmaker has a domestic facility with egg-based vaccine…
Health officials are in talks to deploy Merck & Co.’s experimental Ebola vaccine against a new outbreak in Congo.
Years after winning Provenge's FDA approval—and struggling to make it a commercial success—Dendreon has racked up some data it hopes can help.
Malaria parasites can shuffle genes to create different strains, a phenomenon that could put the efficacy of Glaxo’s vaccine Mosquirix, among others, into…
Takeda’s plan to launch a Hib vaccine in Japan has ended in smoke as GlaxoSmithKline has terminated production of Vaxem Hib.
European biotech Vaximm has partnered with much bigger drug companies Merck KGaA and Pfizer to test a cancer vaccine/checkpoint inhibitor combo.
Sanofi Pasteur’s chief quality officer says vaccinemakers need help tackling a lurking challenge: global regulatory entanglements.
Emergent BioSolutions is one of the vaccine producers that the federal government can tap in case of a virus pandemic.